Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Selleck Chemical LLC Ixazomib (MLN2238) S2180-50mg
SDP

Supplier:  Selleck Chemical LLC S218050MG

Encompass_Preferred

Ixazomib (MLN2238) inhibits the chymotrypsin-like proteolytic ( 5) site of the 20S proteasome with IC50 and Ki of 3 4 nM and 0 93 nM in cell-free assays respectively also inhibits the caspase-like ( 1) and trypsin-like ( 2) proteolytic sites with IC50 of 31 and 3500 nM Ixazomib (MLN2238) induces autophagy Phase 3

Catalog No. 50-311-2320


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.